Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S James

Showing results (1341-1350 of 1,357) with videos related to

Pageof 136
Sort By:
The Journal of Clinical Investigation|April 15, 2022
Combined noncanonical NF-κB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivoShane D Falcinelli, Jackson J Peterson, Anne-Marie W Turner, et al.
The Lancet. Neurology|November 17, 2023
Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trialPerry B Shieh, Nancy L Kuntz, James J Dowling, et al.
Journal of Neuromuscular Diseases|June 13, 2022
INCEPTUS Natural History, Run-in Study for Gene Replacement Clinical Trial in X-Linked Myotubular MyopathyJames J Dowling, Wolfgang Müller-Felber, Barbara K Smith, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|December 7, 2020
Preparations for a European R&D roadmap for an inertial fusion demo reactorP A Norreys, L Ceurvorst, J D Sadler, et al.
Journal of Pain Research|March 19, 2025
An Evidence-Based Consensus for the Use of Neurostimulation for the Treatment of Non-Surgical Low Back Pain: The NEURON GroupTimothy Ray Deer, Jason E Pope, Erika A Petersen, et al.
The Journal of Clinical Investigation|August 5, 2020
Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiencyEnrica Ek Tan, Richard A Hopkins, Chrissie K Lim, et al.
Ebiomedicine|December 12, 2023
Effects of gene replacement therapy with resamirigene bilparvovec (AT132) on skeletal muscle pathology in X-linked myotubular myopathy: results from a substudy of the ASPIRO open-label clinical trialMichael W Lawlor, Benedikt Schoser, Marta Margeta, et al.
Cancer Causes & Control : CCC|February 5, 2013
The 2011-2016 Transdisciplinary Research on Energetics and Cancer (TREC) initiative: rationale and designRuth E Patterson, Graham A Colditz, Frank B Hu, et al.
Nature Communications|March 11, 2022
Divergent trajectories of antiviral memory after SARS-CoV-2 infectionAdriana Tomic, Donal T Skelly, Ane Ogbe, et al.
Drug and Alcohol Dependence|August 15, 2021
Substance use patterns in 9-10 year olds: Baseline findings from the adolescent brain cognitive development (ABCD) studyKrista M Lisdahl, Susan Tapert, Kenneth J Sher, et al.
Pageof 136

Showing results (1341-1350 of 1,357) with videos related to

Sort By:
Pageof 136
The Journal of Clinical Investigation|April 15, 2022
Combined noncanonical NF-κB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivoShane D Falcinelli, Jackson J Peterson, Anne-Marie W Turner, et al.
The Lancet. Neurology|November 17, 2023
Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trialPerry B Shieh, Nancy L Kuntz, James J Dowling, et al.
Journal of Neuromuscular Diseases|June 13, 2022
INCEPTUS Natural History, Run-in Study for Gene Replacement Clinical Trial in X-Linked Myotubular MyopathyJames J Dowling, Wolfgang Müller-Felber, Barbara K Smith, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|December 7, 2020
Preparations for a European R&D roadmap for an inertial fusion demo reactorP A Norreys, L Ceurvorst, J D Sadler, et al.
Journal of Pain Research|March 19, 2025
An Evidence-Based Consensus for the Use of Neurostimulation for the Treatment of Non-Surgical Low Back Pain: The NEURON GroupTimothy Ray Deer, Jason E Pope, Erika A Petersen, et al.
The Journal of Clinical Investigation|August 5, 2020
Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiencyEnrica Ek Tan, Richard A Hopkins, Chrissie K Lim, et al.
Ebiomedicine|December 12, 2023
Effects of gene replacement therapy with resamirigene bilparvovec (AT132) on skeletal muscle pathology in X-linked myotubular myopathy: results from a substudy of the ASPIRO open-label clinical trialMichael W Lawlor, Benedikt Schoser, Marta Margeta, et al.
Cancer Causes & Control : CCC|February 5, 2013
The 2011-2016 Transdisciplinary Research on Energetics and Cancer (TREC) initiative: rationale and designRuth E Patterson, Graham A Colditz, Frank B Hu, et al.
Nature Communications|March 11, 2022
Divergent trajectories of antiviral memory after SARS-CoV-2 infectionAdriana Tomic, Donal T Skelly, Ane Ogbe, et al.
Drug and Alcohol Dependence|August 15, 2021
Substance use patterns in 9-10 year olds: Baseline findings from the adolescent brain cognitive development (ABCD) studyKrista M Lisdahl, Susan Tapert, Kenneth J Sher, et al.
Pageof 136